基于质谱的剥脱性青光眼全面蛋白质组学分析揭示SVEP1为潜在生物标志物
本研究纳入34例剥脱综合征伴或不伴青光眼或年龄相关性白内障患者,采用质谱分析血浆蛋白并结合孟德尔随机化推断关系。2025种血浆蛋白中130种在剥脱性青光眼组差异表达,SVEP1与剥脱性青光眼显著相关(OR=1.20,95%CI=1.10至1.31,P=0.0000428),结论认为SVEP1高表达是剥脱性青光眼的危险因素,但需进一步研究确定因果关系。
要点
- 2025种血浆蛋白中130种在剥脱性青光眼组差异表达,该组眼压升高。
- SVEP1与剥脱性青光眼显著相关(OR=1.20,95%CI=1.10至1.31,P=0.0000428),并在独立队列中得到印证。
- 作者认为SVEP1高表达是剥脱性青光眼的危险因素,但需进一步研究确定因果关系。
核心结论
- 血浆蛋白质组学分析显示SVEP1高表达是剥脱性青光眼的危险因素,可能影响糖尿病并受雌二醇或LOXL1-AS1影响。
- 作者指出仍需进一步研究以确定因果关系。
研究设计与样本
- 研究纳入34例诊断为剥脱综合征伴或不伴青光眼或年龄相关性白内障的患者,分析其血浆蛋白。
- 采用质谱分析血浆蛋白,并基于deCODE、FinnGen、ARIC、eQTLGen和UKB队列数据进行孟德尔随机化推断关系。
主要发现
- 分析的2025种血浆蛋白中,130种在剥脱性青光眼组差异表达,该组眼压升高。
- 蛋白质组学数据提示感染、免疫反应(包括肠道免疫网络)、内分泌激素及补体与凝血级联参与剥脱性青光眼的发生发展。
- SVEP1与剥脱性青光眼显著相关(OR=1.20,95%CI=1.10至1.31,P=0.0000428),并在独立队列中得到印证。
- 进一步分析预测LOXL1-AS1通过调控SVEP1表达对剥脱性青光眼发挥保护作用。
- 在孟德尔随机化全表型关联研究中,SVEP1与剥脱性青光眼的并发症相关。
局限性
- 作者指出仍需进一步研究以确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated the proteomic landscape of exfoliation glaucoma to find potential biomarkers. METHODS: The study enrolled 34 patients diagnosed with either exfoliation syndrome with/without glaucoma or age-related cataract. Plasma proteins were analyzed through mass spectrometry and Mendelian randomization (MR) based on data from deCODE, FinnGen, Atherosclerosis Risk in Communities (ARIC), eQTLGen, and UK Biobank (UKB) cohorts to infer relationships. RESULTS: Among 2025 plasma proteins analyzed, 130 were differentially expressed in the exfoliation glaucoma group, which exhibited elevated intraocular pressure. Our proteomics data suggested that infection, immune responses including intestinal immune network, endocrine hormones, and complement and coagulation cascades are involved in the development of exfoliation glaucoma. Notably, there was a significant correlation between SVEP1 and exfoliation glaucoma (odds ratio [OR] = 1.20, 95% confidence interval [CI] = 1.10 to 1.31, P = 0.0000428), with findings corroborated in an independent cohort. Further analysis predicted a protective role of LOXL1-AS1 in exfoliation glaucoma through its regulation of SVEP1 expression. In MR phenome-wide association studies, SVEP1 was associated with complications of exfoliation glaucoma. After multiple testing corrections, there was a tendency for SVEP1 to be associated with glaucoma (OR = 1.14, 95% CI = 1.11 to 1.16, P = 0.0000003) and type 2 diabetes (OR = 1.07, 95% CI = 1.05 to 1.08, P = 0.0000067). CONCLUSIONS: Plasma proteomic analysis reveals that high expression of SVEP1 is a risk factor for exfoliation glaucoma, which potentially affects diabetes and is affected by estradiol or LOXL1-AS1. However, further research is needed to establish causality.
引用
- Li J, Ma Y, Xie L, et al. Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker. Invest Ophthalmol Vis Sci. 2025. PMID: 40052860. doi:10.1167/iovs.66.3.19
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。